Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing: earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures gives cross-border investors faster access to Tokyo-listed disclosures.
This corporate disclosure from was processed by Pulse News Wire on January 30, 2026. It represents a primary source document for Japanese Earnings sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.
Olba Healthcare Holdings,Inc. Reports Q2
Source disclosure: January 30, 2026
OLBA HEALTHCARE HOLDINGS,Inc. [2689.T]
TOKYO, Feb 17 (Pulse News Wire) – Olba Healthcare Holdings,Inc. (2689.T) reported consolidated results for Q2 FY2026 (ending June 2026).
Revenue was ¥62.4 billion (+3.0% YoY). operating profit was ¥673 million (-16.6%). net profit attributable to shareholders was ¥450 million (-30.5%).
Total assets stood at ¥48.1 billion with an equity ratio of 25.3%. The company declared an annual dividend of ¥80 per share.
TOKYO, Feb 17 (Pulse News Wire) – Olba Healthcare Holdings,Inc. (2689.T) reported consolidated results for Q2 FY2026 (ending June 2026).
4 billion (+3.0% YoY). 6%). net profit attributable to shareholders was ¥450 million (-30.5%).
1 billion with an equity ratio of 25.3%. For the next fiscal year, the company forecasts 3%).
Note: Financial figures from the earnings presentation have been removed pending correction. For accurate figures, refer to the company's earnings summary (kessan tanshin) filed separately on TDNet.